Malignant peripheral nerve sheath tumor causes

Jump to navigation Jump to search

Malignant peripheral nerve sheath tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Malignant peripheral nerve sheath tumor causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Malignant peripheral nerve sheath tumor causes

CDC on Malignant peripheral nerve sheath tumor causes

Malignant peripheral nerve sheath tumor causes in the news

Blogs on Malignant peripheral nerve sheath tumor causes

Directions to Hospitals Treating Malignant peripheral nerve sheath tumor

Risk calculators and risk factors for Malignant peripheral nerve sheath tumor causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Malignant peripheral nerve sheath tumor may be caused by a mutation in the neurofibromatosis type I gene.[1][2]

Causes

  • About half of the cases of malignant peripheral nerve sheath tumor (MPNST) occur along with NF1. The lifetime risk of having both of these conditions is at 8–13% while those with only MPNST have a 0.001% in the general population.[2]
  • The NF1 gene locus is on chromosome 17q11.2 and the gene product is neurofibromin, which acts as a tumor suppressor. Inactivation of the gene predisposes to tumor development.[1]

References

  1. 1.0 1.1 1.2 Albright, A (2008). Principles and practice of pediatric neurosurgery. New York: Thieme. ISBN 1588903958.
  2. 2.0 2.1 2.2 Ferrari, Andrea; Gianni Bisogno; Modesto Carli (2007). "Management Of Childhood Malignant Peripheral Nerve Sheath Tumor". Pediatric Drugs. 9 (4): 239–48. doi:10.2165/00148581-200709040-00005. PMID 17705563. |access-date= requires |url= (help)

Template:WH Template:WS